Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-02

Clinical Trial Update: Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji

View source ↗

Summary

An NIAID-sponsored clinical trial in Fiji evaluated the prevalence of Group A Streptococcal pyoderma (impetigo) and scabies in infants. The study (NCT00436891) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Streptococcus Group A | Status: COMPLETED